hCG

hCG (Human chorionic gonadotropin) is a glycoprotein hormone (not a peptide). The HEIVE catalog describes it as: A pregnancy hormone that reads as LH at the testicular receptor. Licensed for fertility and hypogonadism, and the standard way to keep your own production running on testosterone therapy. It is also known as Human chorionic gonadotropin and Pregnyl.

HEIVE groups hCG under hormonal balance, fertility, libido, motivation and muscle. These catalog categories are not approved indications or evidence that treatment works. See the product-specific regulatory answer below.

Yes, for specific prescription products. FDA describes approved hCG injections for selected female infertility and male hormonal conditions. hCG is not approved for weight loss. Approval of a labeled medicine does not approve an arbitrary research or compounded product containing the same ingredient.

• FDA product data (October 6, 2026)
• FDA hCG questions and answers

The HEIVE editorial risk summary for hCG lists: Injection-site soreness; acne and water retention as testosterone rises; gynecomastia from aromatisation. Longer-term concerns: Sustained high doses desensitise the Leydig cells. Oestradiol needs measuring, not guessing. This is not a complete or clinically reviewed safety assessment; risks depend on the product, route and population.

hCG has no single onset time established by this catalog. The editorial timeline starts with “Weeks 1–2”. These are illustrative model or editorial milestones, not clinically validated outcome predictions.

HEIVE's illustrative catalog entry for hCG: 250–500 IU subcutaneously, two to three times a week. This is not a verified study range or a prescription. A dose cannot be transferred between products, routes or indications; use the specific approved label and the prescribing clinician's instructions where applicable.

The catalog classifies hCG as having human research. Its paper-count snapshot is not a live PubMed search, a count of controlled human trials or proof of safety. This FAQ has not independently validated the catalog's clinical literature claims.

The source catalog lists only injectable forms for hCG; it does not establish that every studied or marketed form is injectable.

Preparation of hCG depends on the exact labeled product. Follow its instructions for formulation, diluent, route and storage. A generic powder recipe must not be applied to a prefilled, ready-to-use or differently formulated product. The catalog's mixing example does not establish sterility or stability.

Storage for hCG depends on the specific formulation (injectable in the source catalog). Follow the product's labeled temperature, light protection and expiry or discard instructions. A general refrigerator or 28-day rule does not establish stability or sterility for every preparation.

The HEIVE editorial summary for hCG: Real at high frequency. Two or three small doses a week beats one large one. This summary is not a clinically validated prediction of tolerance or withdrawal for an individual.

hCG and Kisspeptin-10 share the catalog categories libido, fertility and hormonal balance. hCG: A pregnancy hormone that reads as LH at the testicular receptor. Licensed for fertility and hypogonadism, and the standard way to keep your own production running on testosterone therapy. Kisspeptin-10: The upstream switch of the reproductive axis. It signals the hypothalamus to release GnRH — one step earlier than anything else here acts. This is a catalog comparison, not a head-to-head clinical result or a recommendation to substitute treatments.

• View Kisspeptin-10

The HEIVE editorial summary highlights: Mood and motivation scores often move before testosterone does. The cited study, population and formulation must be checked before treating this summary as a clinical finding; this FAQ does not supply a verified research citation for it.